会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SYSTEMS AND METHODS FOR IMAGING-TREATMENT OF PAIN
    • 用于成像治疗疼痛的系统和方法
    • WO2007035906A3
    • 2009-04-23
    • PCT/US2006036943
    • 2006-09-21
    • UNIV CALIFORNIABRADFORD DAVID SLOTZ JEFFREY C
    • BRADFORD DAVID SLOTZ JEFFREY C
    • A61B5/00A61K51/00
    • A61K51/1096A61B5/4041A61B5/4824A61B6/506A61B18/14A61B2018/00339A61B2018/00577A61B2018/00642A61K49/0002A61M5/007A61M5/1723A61M2230/005A61N7/02
    • Pain factors are labeled with targeted agents or markers delivered into the body. The labeled pain factors are imaged with appropriate imaging tools in a manner allowing selective identification and localization of areas of pain source or transmission. The labeled pain factors allow spatial differentiation in the imaging sufficient to specify the location of the pain so as to drive therapeutic decisions and techniques in order to treat the pain. Pain factors labeled and imaged in this manner may include one or more of nerve factors, blood vessel factors, cellular factors, and inflammation factors. Labeled markers may include for example radioactive materials (e.g. tritiated or iodinated molecules) or other materials such as metal (e.g. gold) nanoparticles. Intermediary binding materials may be used, such as for example bi-specific antibodies. Therapeutic components of the system and method include for example localized energy delivery or ablation treatments, or local drug or other chemical delivery. Locations containing pain factor selectively bound by targeted agents are selectively treated with directed energy into a region containing the targeted agent bound to the pain factor.
    • 疼痛因素用传递到体内的靶向药物或标记进行标记。 标记的疼痛因子以适当的成像工具以允许选择性识别和定位疼痛源或传播区域的方式成像。 标记的疼痛因子允许成像中的空间分化足以指定疼痛的位置,以便驱动治疗决定和技术以治疗疼痛。 以这种方式标记和成像的疼痛因子可包括神经因子,血管因子,细胞因子和炎症因子中的一种或多种。 标记的标记可以包括例如放射性材料(例如氚化或碘化分子)或其它材料,例如金属(例如金)纳米颗粒。 可以使用中间结合材料,例如双特异性抗体。 该系统和方法的治疗组件包括例如局部能量递送或消融治疗,或局部药物或其它化学物质递送。 选择性地由靶向药物结合的含有疼痛因子的位置被选择性地用定向能量处理到含有与疼痛因子结合的靶向药剂的区域中。
    • 10. 发明申请
    • SYSTEMS, COMPOSITIONS, AND METHODS FOR LOCAL IMAGING AND TREATMENT OF PAIN
    • 用于局部成像和治疗疼痛的系统,组合物和方法
    • WO2007035906A2
    • 2007-03-29
    • PCT/US2006/036943
    • 2006-09-21
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIABRADFORD, David, S.LOTZ, Jeffrey, C.
    • BRADFORD, David, S.LOTZ, Jeffrey, C.
    • A61B8/14
    • A61K51/1096A61B5/4041A61B5/4824A61B6/506A61B18/14A61B2018/00339A61B2018/00577A61B2018/00642A61K49/0002A61M5/007A61M5/1723A61M2230/005A61N7/02
    • Pain factors are labeled with targeted agents or markers delivered into the body. The labeled pain factors are imaged with appropriate imaging tools in a manner allowing selective identification and localization of areas of pain source or transmission. The labeled pain factors allow spatial differentiation in the imaging sufficient to specify the location of the pain so as to drive therapeutic decisions and techniques in order to treat the pain. Pain factors labeled and imaged in this manner may include one or more of nerve factors, blood vessel factors, cellular factors, and inflammation factors. Labeled markers may include for example radioactive materials (e.g. tritiated or iodinated molecules) or other materials such as metal (e.g. gold) nanoparticles. Intermediary binding materials may be used, such as for example bi-specific antibodies. Therapeutic components of the system and method include for example localized energy delivery or ablation treatments, or local drug or other chemical delivery. Locations containing pain factor selectively bound by targeted agents are selectively treated with directed energy into a region containing the targeted agent bound to the pain factor.
    • 疼痛因素用传递到体内的靶向药物或标记进行标记。 标记的疼痛因子以适当的成像工具以允许选择性识别和定位疼痛源或传播区域的方式成像。 标记的疼痛因子允许成像中的空间分化足以指定疼痛的位置,以便驱动治疗决定和技术以治疗疼痛。 以这种方式标记和成像的疼痛因子可包括神经因子,血管因子,细胞因子和炎症因子中的一种或多种。 标记的标记可以包括例如放射性材料(例如氚化或碘化分子)或其它材料,例如金属(例如金)纳米颗粒。 可以使用中间结合材料,例如双特异性抗体。 该系统和方法的治疗组件包括例如局部能量递送或消融治疗,或局部药物或其它化学物质递送。 选择性地由靶向药物结合的含有疼痛因子的位置被选择性地用定向能量处理到含有与疼痛因子结合的靶向药剂的区域中。